References
Albuquerque, T. A. F., Drummond do Val, L., Doherty, A. & de Magalhães, J. P. From humans to hydra: patterns of cancer across the tree of life. Biol. Rev. Camb. Philos. Soc. 93, 1715–1734 (2018).
Vincze, O. et al. Cancer risk across mammals. Nature 601, 263–267 (2022).
Compton, Z. T. et al. Cancer prevalence across vertebrates. Cancer Discov. 15, 227–244 (2025).
de Magalhaes, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357–365 (2013).
DeGregori, J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 71, 3739–3744 (2011).
Steliarova-Foucher, E. et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 18, 719–731 (2017).
Avraam, D., de Magalhaes, J. P. & Vasiev, B. A mathematical model of mortality dynamics across the lifespan combining heterogeneity and stochastic effects. Exp. Gerontol. 48, 801–811 (2013).
Lynch, H. E. et al. Thymic involution and immune reconstitution. Trends Immunol. 30, 366–373 (2009).
Yun, M. H. Changes in regenerative capacity through lifespan. Int. J. Mol. Sci. 16, 25392–25432 (2015).
Martin, G. M. The genetics and epigenetics of altered proliferative homeostasis in ageing and cancer. Mech. Ageing Dev. 128, 9–12 (2007).
Schmucker, D. L. & Sanchez, H. Liver regeneration and aging: a current perspective. Curr. Gerontol. Geriatr. Res. 2011, 526379 (2011).
Gerstein, A. D., Phillips, T. J., Rogers, G. S. & Gilchrest, B. A. Wound healing and aging. Dermatol. Clin. 11, 749–757 (1993).
Wolf, A. M. The tumor suppression theory of aging. Mech. Ageing Dev. 200, 111583 (2021).
Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513–522 (2005).
Ren, P., Zhang, J. & Vijg, J. Somatic mutations in aging and disease. Geroscience 46, 5171–5189 (2024).
Finch, C. E. Longevity, Senescence, and the Genome (The Univ. Chicago Press, 1990).
Reinke, B. A. et al. Diverse aging rates in ectothermic tetrapods provide insights for the evolution of aging and longevity. Science 376, 1459–1466 (2022).
Voituron, Y., de Fraipont, M., Issartel, J., Guillaume, O. & Clobert, J. Extreme lifespan of the human fish (Proteus anguinus): a challenge for ageing mechanisms. Biol. Lett. 7, 105–107 (2011).
Cayuela, H. et al. Slow life-history strategies are associated with negligible actuarial senescence in western Palaearctic salamanders. Proc. Biol. Sci. 286, 20191498 (2019).
Harper, J. M., Leathers, C. W. & Austad, S. N. Does caloric restriction extend life in wild mice? Aging Cell 5, 441–449 (2006).
Gorbunova, V., Seluanov, A., Zhang, Z., Gladyshev, V. N. & Vijg, J. Comparative genetics of longevity and cancer: insights from long-lived rodents. Nat. Rev. Genet. 15, 531–540 (2014).
Oka, K., Yamakawa, M., Kawamura, Y., Kutsukake, N. & Miura, K. The naked mole-rat as a model for healthy aging. Annu. Rev. Anim. Biosci. 11, 207–226 (2023).
Butler, G., Baker, J., Amend, S. R., Pienta, K. J. & Venditti, C. No evidence for Peto’s paradox in terrestrial vertebrates. Proc. Natl Acad. Sci. USA 122, e2422861122 (2025).
Seluanov, A., Gladyshev, V. N., Vijg, J. & Gorbunova, V. Mechanisms of cancer resistance in long-lived mammals. Nat. Rev. Cancer 18, 433–441 (2018).
Leroi, A. M., Koufopanou, V. & Burt, A. Cancer selection. Nat. Rev. Cancer 3, 226–231 (2003).
Cagan, A. et al. Somatic mutation rates scale with lifespan across mammals. Nature 604, 517–524 (2022).
Vogelstein, B. & Kinzler, K. W. The multistep nature of cancer. Trends Genet. 9, 138–141 (1993).
Chatsirisupachai, K. & de Magalhães, J. P. Somatic mutations in human ageing: new insights from DNA sequencing and inherited mutations. Ageing Res. Rev. 96, 102268 (2024).
Robinson, P. S. et al. Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Nat. Genet. 53, 1434–1442 (2021).
Robinson, P. S. et al. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells. Nat. Commun. 13, 3949 (2022).
Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13 (2011).
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
Jassim, A., Rahrmann, E. P., Simons, B. D. & Gilbertson, R. J. Cancers make their own luck: theories of cancer origins. Nat. Rev. Cancer 23, 710–724 (2023).
Sell, S. On the stem cell origin of cancer. Am. J. Pathol. 176, 2584–2494 (2010).
Tomasetti, C., Li, L. & Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355, 1330–1334 (2017).
Zhuang, X. et al. Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis. Nature 637, 184–194 (2025).
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Brunet, A., Goodell, M. A. & Rando, T. A. Ageing and rejuvenation of tissue stem cells and their niches. Nat. Rev. Mol. Cell Biol. 24, 45–62 (2023).
Oh, J., Lee, Y. D. & Wagers, A. J. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat. Med. 20, 870–880 (2014).
Dos Santos, G. A., Magdaleno, G. D. V. & de Magalhães, J. P. Evidence of a pan-tissue decline in stemness during human aging. Aging 16, 5796–5810 (2024).
de Magalhães, J. P. Distinguishing between driver and passenger mechanisms of aging. Nat. Genet. 56, 204–211 (2024).
Rose, M. R. Evolutionary Biology of Aging (Oxford Univ. Press, 1991).
Medawar, P. B. An Unsolved Problem of Biology (H. K. Lewis, 1952).
Williams, G. C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398–411 (1957).
Austad, S. N. & Hoffman, J. M. Is antagonistic pleiotropy ubiquitous in aging biology? Evol. Med. Public Health 2018, 287–294 (2018).
Carter, A. J. & Nguyen, A. Q. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med. Genet. 12, 160 (2011).
Shokeir, M. H. Investigation on Huntington’s disease in the Canadian prairies. II. Fecundity and fitness. Clin. Genet. 7, 349–353 (1975).
Sørensen, S. A., Fenger, K. & Olsen, J. H. Significantly lower incidence of cancer among patients with Huntington disease: an apoptotic effect of an expanded polyglutamine tract? Cancer 86, 1342–1346 (1999).
Bae, B. I. et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington’s disease. Neuron 47, 29–41 (2005).
Denoth Lippuner, A., Julou, T. & Barral, Y. Budding yeast as a model organism to study the effects of age. FEMS Microbiol. Rev. 38, 300–325 (2014).
Schaible, R. et al. Constant mortality and fertility over age in Hydra. Proc. Natl Acad. Sci. USA 112, 15701–15706 (2015).
Domazet-Lošo, T. et al. Naturally occurring tumours in the basal metazoan Hydra. Nat. Commun. 5, 4222 (2014).
Ou, L. et al. Animal models of cardiac disease and stem cell therapy. Open Cardiovasc. Med. J. 4, 231–239 (2010).
Chen, Z. Y. & Zhang, Y. Animal models of Alzheimer’s disease: applications, evaluation, and perspectives. Zool. Res. 43, 1026–1040 (2022).
West, M. D. et al. Toward a unified theory of aging and regeneration. Regen. Med. 14, 867–886 (2019).
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L. & Kroemer, G. Meta-hallmarks of aging and cancer. Cell Metab. 35, 12–35 (2023).
Montégut, L., López-Otín, C. & Kroemer, G. Aging and cancer. Mol. Cancer 23, 106 (2024).
Aunan, J. R., Cho, W. C. & Søreide, K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 8, 628–642 (2017).
Henry, C. J. & DeGregori, J. Modelling the ageing dependence of cancer evolutionary trajectories. Nat. Rev. Cancer https://doi.org/10.1038/s41568-025-00838-3 (2025).
Chatsirisupachai, K., Palmer, D., Ferreira, S. & de Magalhães, J. P. A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence. Aging Cell 18, e13041 (2019).
Aramillo Irizar, P. et al. Transcriptomic alterations during ageing reflect the shift from cancer to degenerative diseases in the elderly. Nat. Commun. 9, 327 (2018).
Gomes, N. M. et al. Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination. Aging Cell 10, 761–768 (2011).
Seluanov, A. et al. Distinct tumor suppressor mechanisms evolve in rodent species that differ in size and lifespan. Aging Cell 7, 813–823 (2008).
Tian, X. et al. Evolution of telomere maintenance and tumour suppressor mechanisms across mammals. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 20160443 (2018).
Rangarajan, A., Hong, S. J., Gifford, A. & Weinberg, R. A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171–183 (2004).
de Magalhaes, J. P., Costa, J. & Church, G. M. An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts. J. Gerontol. A Biol. Sci. Med. Sci. 62, 149–160 (2007).
Kuo, C. L., Pilling, L. C., Kuchel, G. A., Ferrucci, L. & Melzer, D. Telomere length and aging-related outcomes in humans: a Mendelian randomization study in 261,000 older participants. Aging Cell 18, e13017 (2019).
Gurinovich, A. et al. SNP rs6543176 is associated with extreme human longevity but increased risk for cancer. Geroscience 47, 3163–3168 (2025).
Narita, M. Cellular senescence and chromatin organisation. Br. J. Cancer 96, 686–691 (2007).
Sharpless, N. E. & DePinho, R. A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 113, 160–168 (2004).
Pelicci, P. G. Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J. Clin. Invest. 113, 4–7 (2004).
Pardal, R., Molofsky, A. V., He, S. & Morrison, S. J. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb. Symp. Quant. Biol. 70, 177–185 (2005).
Zhang, Z. et al. Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice. Nature 621, 196–205 (2023).
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W. & Shay, J. W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173–179 (1996).
Bedelbaeva, K. et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc. Natl Acad. Sci. USA 107, 5845–5850 (2010).
Rodier, F., Campisi, J. & Bhaumik, D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 35, 7475–7484 (2007).
Hesse, R. G., Kouklis, G. K., Ahituv, N. & Pomerantz, J. H. The human ARF tumor suppressor senses blastema activity and suppresses epimorphic tissue regeneration. eLife 4, e07702 (2015).
Wang, H. et al. Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation. Cell Rep. 42, 112830 (2023).
Cai, Y. et al. Decoding aging-dependent regenerative decline across tissues at single-cell resolution. Cell Stem Cell 30, 1674–1691.e8 (2023).
Glaberman, S. et al. Do turtles get cancer? BioScience https://doi.org/10.1093/biosci/biaf100 (2025).
Joven, A., Elewa, A. & Simon, A. Model systems for regeneration: salamanders. Development 146, dev167700 (2019).
Yun, M. H. Salamander insights into ageing and rejuvenation. Front. Cell Dev. Biol. 9, 689062 (2021).
de Magalhães, J. P. The longevity bottleneck hypothesis: could dinosaurs have shaped ageing in present-day mammals? Bioessays 46, e2300098 (2024).
Chu, X. L. et al. Temperature responses of mutation rate and mutational spectrum in an Escherichia coli strain and the correlation with metabolic rate. BMC Evol. Biol. 18, 126 (2018).
Lindahl, T. & Nyberg, B. Rate of depurination of native deoxyribonucleic acid. Biochemistry 11, 3610–3618 (1972).
Lindgren, D. The temperature influence on the spontaneous mutation rate. I. Literature review. Hereditas 70, 165–178 (1972).
Hirose, K. et al. Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science 364, 184–188 (2019).
Hayek, S. et al. Prevalence and predictors of frailty in childhood cancer survivors and siblings: a report from the childhood cancer survivor study. J. Clin. Oncol. 38, 232–247 (2020).
Strongman, H. et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet 394, 1041–1054 (2019).
Wang, S., Prizment, A., Thyagarajan, B. & Blaes, A. Cancer treatment-induced accelerated aging in cancer survivors: biology and assessment. Cancers 13, 427 (2021).
Gems, D. & Kern, C. C. Biological constraint, evolutionary spandrels and antagonistic pleiotropy. Ageing Res. Rev. 101, 102527 (2024).
Gould, S. J. The evolutionary biology of constraint. Daedalus 109, 39–52 (1980).
Wilkinson, J. E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675–682 (2012).
Longo, V. D. & Fontana, L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol. Sci. 31, 89–98 (2010).
de Magalhaes, J. P. Ageing as a software design flaw. Genome Biol. 24, 51 (2023).
Jing, J. et al. Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies. Signal Transduct. Target. Ther. 8, 315 (2023).
Shin, K. et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110–114 (2011).
Cho, A. et al. An endogenous anti-aging factor, sonic hedgehog, suppresses endometrial stem cell aging through SERPINB2. Mol. Ther. 27, 1286–1298 (2019).
Maeso-Díaz, R. et al. Aging reduces liver resiliency by dysregulating Hedgehog signaling. Aging Cell 21, e13530 (2022).
Rallis, A. et al. Hedgehog signaling modulates glial proteostasis and lifespan. Cell Rep. 30, 2627–2643.e5 (2020).
Liao, X. et al. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 30, 131–140 (2009).
Ok, C. Y., Singh, R. R. & Vega, F. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am. J. Pathol. 180, 2–11 (2012).
Watkins, D. N. et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313–317 (2003).
Karhadkar, S. S. et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707–712 (2004).
Power, J. D. & Schlaggar, B. L. Neural plasticity across the lifespan. Wiley Interdiscip. Rev. Dev. Biol. https://doi.org/10.1002/wdev.216 (2017).
Johnstone, S. E. et al. Large-scale topological changes restrain malignant progression in colorectal cancer. Cell 182, 1474–1489.e23 (2020).
Johnstone, S. E., Gladyshev, V. N., Aryee, M. J. & Bernstein, B. E. Epigenetic clocks, aging, and cancer. Science 378, 1276–1277 (2022).
Abad, M. et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502, 340–345 (2013).
Ohnishi, K. et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156, 663–677 (2014).
Taguchi, J. et al. DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency. Nat. Commun. 12, 5041 (2021).
Huyghe, A., Trajkova, A. & Lavial, F. Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective. Trends Cell Biol. 34, 255–267 (2024).
Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719–1733.e12 (2016).
Chen, Y. et al. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science 373, 1537–1540 (2021).